Evidence map›Paper›PMID 30721528›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2019

Slc20a2, Encoding the Phosphate Transporter PiT2, Is an Important Genetic Determinant of Bone Quality and Strength.

Sarah Beck-Cormier, Christopher J Lelliott, John G Logan, David T Lafont, Laure Merametdjian, Victoria D Leitch, Natalie C Butterfield, Hayley J Protheroe, Peter I Croucher, Paul A Baldock and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Hormonal regulation of biomineralization.Nature reviews. Endocrinology · 2021
    Review
  17. Article
  18. Frontiers in genetics · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 3 countries.

Sarah Beck-CormierINSERM, UMR 1229, Regenerative Medicine and Skeleton (RMeS), Université de Nantes, École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation, Nantes-Atlantique (ONIRIS), Nantes, France.
Christopher J LelliottMouse Pipelines, Wellcome Trust Sanger Institute, Hinxton, UK.
John G LoganMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
David T LafontMouse Pipelines, Wellcome Trust Sanger Institute, Hinxton, UK.
Laure MerametdjianINSERM, UMR 1229, Regenerative Medicine and Skeleton (RMeS), Université de Nantes, École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation, Nantes-Atlantique (ONIRIS), Nantes, France.
Victoria D LeitchMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
Natalie C ButterfieldMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
Hayley J ProtheroeMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
Peter I CroucherThe Garvan Institute of Medical Research, Sydney, NSW, Australia.
Paul A BaldockThe Garvan Institute of Medical Research, Sydney, NSW, Australia.
Alina Gaultier-LintiaCentre Hospitalier Universitaire (CHU) Nantes, Laennec Hospital, Nantes, France.
Yves MaugarsINSERM, UMR 1229, Regenerative Medicine and Skeleton (RMeS), Université de Nantes, École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation, Nantes-Atlantique (ONIRIS), Nantes, France.
Gael NicolasINSERM U1245, Université de Rouen Normandie (UNIROUEN), Rouen, France.
Christopher BanseDepartment of Rheumatology, Soissons Hospital, Soissons, France.
Sébastien NormantDepartment of Neuroradiology, Rouen University Hospital, Rouen, France.
Nicolas MagneDepartment of Neuroradiology, Rouen University Hospital, Rouen, France.
Emmanuel GérardinDepartment of Neuroradiology, Rouen University Hospital, Rouen, France.
Nina BonINSERM, UMR 1229, Regenerative Medicine and Skeleton (RMeS), Université de Nantes, École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation, Nantes-Atlantique (ONIRIS), Nantes, France.
Sophie SouriceINSERM, UMR 1229, Regenerative Medicine and Skeleton (RMeS), Université de Nantes, École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation, Nantes-Atlantique (ONIRIS), Nantes, France.
Jérôme GuicheuxINSERM, UMR 1229, Regenerative Medicine and Skeleton (RMeS), Université de Nantes, École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation, Nantes-Atlantique (ONIRIS), Nantes, France.
Laurent BeckINSERM, UMR 1229, Regenerative Medicine and Skeleton (RMeS), Université de Nantes, École Nationale Vétérinaire, Agroalimentaire et de l'Alimentation, Nantes-Atlantique (ONIRIS), Nantes, France.
Graham R WilliamsMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
J H Duncan BassettMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, UK.
Imperial College London · GBCentre Hospitalier Universitaire de Nantes · FROniris · FRUniversité de Rouen Normandie · FRWellcome Sanger Institute · GBFish Physiology and Genomics Institute · FRGarvan Institute of Medical Research · AUInserm · FRNantes Université · FRUNSW Sydney · AU

Funding

Wellcome Trust
6 · The paper itself

Abstract

Osteoporosis is characterized by low bone mineral density (BMD) and fragility fracture and affects over 200 million people worldwide. Bone quality describes the material properties that contribute to strength independently of BMD, and its quantitative analysis is a major priority in osteoporosis research. Tissue mineralization is a fundamental process requiring calcium and phosphate transporters. Here we identify impaired bone quality and strength in Slc20a2

Indexed as

AnimalsAnimals, NewbornBone and BonesBone DevelopmentBone ResorptionCalcification, PhysiologicCalcinosisCells, CulturedChondrocytesHumansIncisorMice, Inbred C57BLMice, KnockoutOsteoblastsPhenotypeSkullSLC20A2 protein, humanSlc20a2 protein, mouseSodium-Phosphate Cotransporter Proteins, Type IIIANIMAL MODELS (GENETIC ANIMAL MODELS)BONE MATRIX (MATRIX MINERALIZATION)DISORDERS OF CALCIUM/PHOSPHATE METABOLISM (OTHER)GENETIC RESEARCH (HUMAN ASSOCIATION STUDIES)ORTHOPAEDICS (BIOMECHANICS)

Identifiers

PMID30721528
PMCPMC6618161
OpenAlexW2911782269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.